Back to Search
Start Over
Effect of Monthly, High-Dose, Long-Term Vitamin D Supplementation on Central Blood Pressure Parameters: A Randomized Controlled Trial Substudy.
- Source :
-
Journal of the American Heart Association [J Am Heart Assoc] 2017 Oct 24; Vol. 6 (10). Date of Electronic Publication: 2017 Oct 24. - Publication Year :
- 2017
-
Abstract
- Background: The effects of monthly, high-dose, long-term (≥1-year) vitamin D supplementation on central blood pressure (BP) parameters are unknown.<br />Methods and Results: A total of 517 adults (58% male, aged 50-84 years) were recruited into a double-blinded, placebo-controlled trial substudy and randomized to receive, for 1.1 years (median; range: 0.9-1.5 years), either (1) vitamin D <subscript>3</subscript> 200 000 IU (initial dose) followed 1 month later by monthly 100 000-IU doses (n=256) or (2) placebo monthly (n=261). At baseline (n=517) and follow-up (n=380), suprasystolic oscillometry was undertaken, yielding aortic BP waveforms and hemodynamic parameters. Mean deseasonalized 25-hydroxyvitamin D increased from 66 nmol/L (SD: 24) at baseline to 122 nmol/L (SD: 42) at follow-up in the vitamin D group, with no change in the placebo group. Despite small, nonsignificant changes in hemodynamic parameters in the total sample (primary outcome), we observed consistently favorable changes among the 150 participants with vitamin D deficiency (<50 nmol/L) at baseline. In this subgroup, mean changes in the vitamin D group (n=71) versus placebo group (n=79) were -5.3 mm Hg (95% confidence interval [CI], -11.8 to 1.3) for brachial systolic BP ( P =0.11), -2.8 mm Hg (95% CI, -6.2 to 0.7) for brachial diastolic BP ( P =0.12), -7.5 mm Hg (95% CI, -14.4 to -0.6) for aortic systolic BP ( P =0.03), -5.7 mm Hg (95% CI, -10.8 to -0.6) for augmentation index ( P =0.03), -0.3 m/s (95% CI, -0.6 to -0.1) for pulse wave velocity ( P =0.02), -8.6 mm Hg (95% CI, -15.4 to -1.9) for peak reservoir pressure ( P =0.01), and -3.6 mm Hg (95% CI, -6.3 to -0.8) for backward pressure amplitude ( P =0.01).<br />Conclusions: Monthly, high-dose, 1-year vitamin D supplementation lowered central BP parameters among adults with vitamin D deficiency but not in the total sample.<br />Clinical Trial Registration: URL: http://www.anzctr.org.au. Unique identifier: ACTRN12611000402943.<br /> (© 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.)
- Subjects :
- Aged
Aged, 80 and over
Antihypertensive Agents therapeutic use
Biomarkers blood
Brachial Artery physiopathology
Cholecalciferol adverse effects
Cholecalciferol blood
Double-Blind Method
Drug Administration Schedule
Female
Humans
Hypertension blood
Hypertension diagnosis
Hypertension physiopathology
Intention to Treat Analysis
Male
Middle Aged
New Zealand
Pulse Wave Analysis
Time Factors
Treatment Outcome
Vitamin D analogs & derivatives
Vitamin D blood
Vitamin D Deficiency blood
Vitamin D Deficiency diagnosis
Vitamin D Deficiency physiopathology
Blood Pressure drug effects
Brachial Artery drug effects
Cholecalciferol administration & dosage
Dietary Supplements adverse effects
Hypertension drug therapy
Vitamin D Deficiency drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 2047-9980
- Volume :
- 6
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Journal of the American Heart Association
- Publication Type :
- Academic Journal
- Accession number :
- 29066444
- Full Text :
- https://doi.org/10.1161/JAHA.117.006802